Orteq Sports Medicine is an orthobiologics company that has created two breakthrough products for Regeneration and Repair of damaged menisci and cartilage in the knee. The Company’s lead products, Actifit® and CartiONE are next generation regenerative medicine products, for patients with painful, debilitating, otherwise irreparable meniscus or cartilage damage. Rigorous 2-year clinical trials on each product established that the products demonstrated clinically significant reduction of pain and restoration of function throughout the 2 year follow-up periods allowing patients to return to a normal life and pre-injury sporting activity. These clinical studies were used to achieve CE Marking for both technologies allowing the commercial sales in those markets that accept the CE Mark. Orteq is launching the CartiONE process in the US in 2015 and will discuss the Actifit status with the FDA to bring to bear 3200+ implantations and 7 years of clinical usage and outstanding outcomes to the US regulatory process.